ArticleFrontiers in oncology2022

Real-World Estimation of First- and Second-Line Treatments for Diffuse Large B-Cell Lymphoma Using Health Insurance Data: A Belgian Population-Based Study.

Willem Daneels et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.